evidence table
Coenzyme Q10 Fatigue Randomized Trial Evidence Table
Structured evidence table for Coenzyme Q10 Fatigue Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Coenzyme Q10 Fatigue Randomized Trial | The results demonstrated that oral coenzyme Q10 elevated blood coenzyme Q10 concentration (standardized mean difference: 2.710, 95% confidence interval: 1.57-3.85, p < 0.00001) and reduced blood malondialdehyde concentration (standardized mean difference: -0.289, 95% confidence interval: -0.541 to -0.038, p = 0.024). | 1 | Zhang Y (2026) | Effects of coenzyme Q10 analogs on oxidative stress, muscle, and metabolism after exercise: A meta-analysis and systematic review. |
| Coenzyme Q10 Fatigue Randomized Trial | Additionally, oral coenzyme Q10 was found to reduce blood creatine kinase values (standardized mean difference: -1.532, 95% confidence interval: -2.856 to -0.209, p = 0.023), suggesting a potential protective effect on skeletal muscle. | 1 | Zhang Y (2026) | Effects of coenzyme Q10 analogs on oxidative stress, muscle, and metabolism after exercise: A meta-analysis and systematic review. |
| Coenzyme Q10 Fatigue Randomized Trial | Quantitative and qualitative analyses were performed.ResultsThe study screened 14 randomized controlled trials that included a total of 433 subjects. | 1 | Zhang Y (2026) | Effects of coenzyme Q10 analogs on oxidative stress, muscle, and metabolism after exercise: A meta-analysis and systematic review. |
| Coenzyme Q10 Fatigue Randomized Trial | Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities | 4 | Baptista S (2026) | Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities |
Source documents